Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2020-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, dividend decisions, appointment of auditors, and changes to business objectives. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2020-03-24 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It specifically details a correction (정정신고) to a previously reported contract amount. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into the other specialized categories like M&A or financial reports, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous regulatory announcements.
2020-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from the Korean stock exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data, and auditor information for the fiscal year. While it contains financial data, it is a formal notification of the filing of an audit report rather than the full annual report itself, and it fits the criteria for a regulatory filing announcement regarding the submission of audit results. FY 2019
2020-03-16 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Jeonjin Bio-Pharm Co., Ltd. It contains the meeting agenda, details on board activities, and financial statements (balance sheet, income statement) to be approved by shareholders. This type of document, which provides information to shareholders to solicit their votes for an upcoming meeting, is classified as a Proxy Solicitation & Information Statement.
2020-03-09 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Proxy Solicitation & Information Statement' (PSI) filed by Jeonjin BioPharm. It contains information regarding the solicitation of voting rights for the 16th Annual General Meeting, including details about the solicitor, the purpose of the meeting, and the agenda items (financial statements). It also includes detailed financial statements (balance sheet, income statement, cash flow statement) as part of the reference materials for shareholders. It is not an Annual Report (10-K) as it is specifically structured as a proxy solicitation document for an upcoming meeting.
2020-03-09 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Jeonjin BioPharm. It outlines the date, location, and agenda items (such as financial statement approval, articles of incorporation changes, and director/auditor compensation). This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of upcoming meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2020-03-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.